Inhibition of biofilm formation by Camelid single-domain antibodies against the flagellum of Pseudomonas aeruginosa

Journal of Biotechnology

Volumn 186, Issue , 2014, Pages 66-73

  Adams, Hendrik ^a,b   Horrevoets, Wannie M ^a   Adema, Simon M ^a   Carr, Hannah E V ^a   van Woerden, Richard E ^b   Koster, Margot ^b   Tommassen, Jan ^b  

^a BAC BV   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Biofilm; Camelid single domain antibodies; Flagellum; Pseudomonas aeruginosa; VHH

Indexed keywords

BACTERIA; BIOFILMS; CELLS; DRUG THERAPY; YEAST;

CELL-SURFACE INTERACTIONS; FLAGELLUM; HEAVY-CHAIN ANTIBODIES; HOSPITAL ACQUIRED INFECTION; INTRINSIC RESISTANCE; PSEUDOMONAS AERUGINOSA; SINGLE-DOMAIN ANTIBODIES; VHH; BIOFILM FORMATION;

ANTIBODIES; BIOFILMS;

FLAGELLIN; FLAGELLIN ANTIBODY; NANOBODY; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ARTICLE; ARTIODACTYLA; BACTERIAL CELL; BACTERIAL GROWTH; BIOFILM; CELL SURFACE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLAGELLUM; IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SACCHAROMYCES CEREVISIAE; SURFACE PLASMON RESONANCE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; BACTERIAL FLAGELLUM; BACTERIAL STRAIN; BINDING AFFINITY; CONTROLLED STUDY; HEAVY CHAIN; IN VITRO STUDY; SWIMMING; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; NEW WORLD CAMELID; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; CAMELIDS, NEW WORLD; FLAGELLA; FLAGELLIN; MOLECULAR SEQUENCE DATA; PSEUDOMONAS AERUGINOSA; SEQUENCE ALIGNMENT; SINGLE-DOMAIN ANTIBODIES;

EID: 84904410812     PISSN: 01681656     EISSN: 18734863     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2014.06.029     Document Type: Article

References (27)

1. Adams H., Brummelhuis W., Maassen B., van Egmond N., El Khattabi M., Detmers F., Hermans P., Braam B., Stam J., Verrips T. Specific immuno capturing of the staphylococcal superantigen toxic-shock syndrome toxin-1 in plasma. Biotechnol. Bioeng. 2009, 104:143-151.
2. Banin E., Vasil M.L., Greenberg E.P. Iron and Pseudomonas aeruginosa biofilm formation. Proc. Nat. Acad. Sci. U.S.A. 2005, 102:11076-11081.
3. de Marco A. Biotechnological applications of recombinant single-domain antibody fragments. Microb. Cell Fact. 2011, 10:44.
4. Dioszeghy Z., Zavodszky P., Namba K., Vonderviszt F. Stabilization of flagellar filaments by HAP2 capping. FEBS Lett. 2004, 568:105-109.
5. El Khattabi M., Adams H., Heezius E., Hermans P., Detmers F., Maassen B., van der Ley P., Tommassen J., Verrips T., Stam J. Llama single-chain antibody that blocks lipopolysaccharide binding and signaling: prospects for therapeutic applications. Clin. Vaccine Immunol. 2006, 13:1079-1086.
6. Feldman M., Bryan R., Rajan S., Scheffler L., Brunnert S., Tang H., Prince A. Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect. Immun. 1998, 66:43-51.
7. Feuillet V., Medjane S., Mondor I., Demaria O., Pagni P.P., Galan J.E., Flavell R.A., Alexopoulou L. Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria. Proc. Nat. Acad. Sci. U.S.A. 2006, 103:12487-12492.
8. Frenken L.G., van der Linden R.H., Hermans P.W., Bos J.W., Ruuls R.C., de Geus B., Verrips C.T. Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae. J. Biotechnol. 2000, 78:11-21.
9. Guttenplan S.B., Kearns D.B. Regulation of flagellar motility during biofilm formation. FEMS Microbiol. Rev. 2013, 37:849-871.
10. Hamers-Casterman C., Atarhouch T., Muyldermans S., Robinson G., Hamers C., Songa E.B., Bendahman N., Hamers R. Naturally occurring antibodies devoid of light chains. Nature 1993, 363:446-448.
11. Holloway B.W. Genetics of Pseudomonas. Bacteriol. Rev. 1969, 33:419-443.
12. Jacobs M.A., Alwood A., Thaipisuttikul I., Spencer D., Haugen E., Ernst S., Will O., Kaul R., Raymond C., Levy R., Chun-Rong L., Guenthner D., Bovee D., Olson M.V., Manoil C. Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc. Nat. Acad. Sci. U.S.A. 2003, 100:14339-14344.
13. Joo H.S., Otto M. Molecular basis of in vivo biofilm formation by bacterial pathogens. Chem. Biol. 2012, 19:1503-1513.
14. Klausen M., Heydorn A., Ragas P., Lambertsen L., Aaes-Jorgensen A., Molin S., Tolker-Nielsen T. Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol. Microbiol. 2003, 48:1511-1524.
15. Landsperger W.J., Kelly-Wintenberg K.D., Montie T.C., Knight L.S., Hansen M.B., Huntenburg C.C., Schneidkraut M.J. Inhibition of bacterial motility with human antiflagellar monoclonal antibodies attenuates Pseudomonas aeruginosa-induced pneumonia in the immunocompetent rat. Infect. Immun. 1994, 62:4825-4830.
16. Montie T.C., Craven R.C., Holder I.A. Flagellar preparations from Pseudomonas aeruginosa: isolation and characterization. Infect. Immun. 1982, 35:281-288.
17. Muyldermans S. Nanobodies: natural single-domain antibodies. Annu. Rev. Biochem. 2013, 82:775-797.
18. O'Toole G.A., Kolter R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol. Microbiol. 1998, 30:295-304.
19. O'Toole G.A., Kolter R. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol. Microbiol. 1998, 28:449-461.
20. Ramphal R., Arora S.K., Ritchings B.W. Recognition of mucin by the adhesin-flagellar system of Pseudomonas aeruginosa. Am. J. Respir. Crit. Care Med. 1996, 154:S170-S174.
21. Riazi A., Strong P.C., Coleman R., Chen W., Hirama T., van Faassen H., Henry M., Logan S.M., Szymanski C.M., Mackenzie R., Ghahroudi M.A. Pentavalent single-domain antibodies reduce Campylobacter jejuni motility and colonization in chickens. PLoS One 2013, 8:e83928.
22. Spangenberg C., Heuer T., Burger C., Tummler B. Genetic diversity of flagellins of Pseudomonas aeruginosa. FEBS Lett. 1996, 396:213-217.
23. Tashiro Y., Nomura N., Nakao R., Senpuku H., Kariyama R., Kumon H., Kosono S., Watanabe H., Nakajima T., Uchiyama H. Opr86 is essential for viability and is a potential candidate for a protective antigen against biofilm formation by Pseudomonas aeruginosa. J. Bacteriol. 2008, 190:3969-3978.
24. Totten P.A., Lory S. Characterization of the type a flagellin gene from Pseudomonas aeruginosa PAK. J. Bacteriol. 1990, 172:7188-7199.
25. Verheesen P., Roussis A., de Haard H.J., Groot A.J., Stam J.C., den Dunnen J.T., Frants R.R., Verkleij A.J., Theo Verrips C., van der Maarel S.M. Reliable and controllable antibody fragment selections from Camelid non-immune libraries for target validation. Biochim. Biophys. Acta 2006, 1764:1307-1319.
26. Verheesen P., ten Haaft M.R., Lindner N., Verrips C.T., de Haard J.J. Beneficial properties of single-domain antibody fragments for application in immunoaffinity purification and immuno-perfusion chromatography. Biochim. Biophys. Acta 2003, 1624:21-28.
27. Ye J., Ma N., Madden T.L., Ostell J.M. IgBLAST: an immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res. 2013, 41:W34-W40.